Logo: Boehringer Ingelheim
Home
  • About us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Science
    • Therapeutic Vaccines
    • KISIMA®
    • Publications
  • Pipeline
  • Partnering
    • Partnering at AMAL Therapeutics
    • Partnering at Boehringer Ingelheim
  • Media
    • News
    • Events
  • Careers
  • Contact

Season Greetings

A very happy holiday season from the whole AMAL team, and a great start into 2022 !

AMAL Therapeutics to publish research outcomes in CancersJoint Team Effort Succeeds in Advancing First-in-Cass Triple Combination Immunotherapy to Studies in Patients with Colorectal Cancer

Share this entry

Amal Therapeutics SA
c/o Fondation pour Recherches Médicales
64 av. de la Roseraie
1205 Geneva
Switzerland

  • Privacy Policy
  • Contact us